You are here

  • Home
  • Archive
  • Volume 6, Issue Suppl 1
  • 209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension

Citation Tools

Article menu

Download PDFPDF

Abstracts
209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Morand E, T Merrill J, A Isenberg D, et al
209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension
Lupus Science & Medicine 2019;6:doi: 10.1136/lupus-2019-lsm.209